Location: Fort Smith AR, Little Rock AR, Fountain Valley CA,
Sponsor: Target PharmaSolutions, Inc.
Sex: All
Age: 0+
Code: NCT03661866
Recruiting
Active & Responsive
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
for
Psoriasis, Overweight or Obesity
Location: Phoenix AZ, Fountain Valley CA, Fremont CA,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT06857942
Recruiting
Active & ResponsiveNew
Impact of Tildrakizumab on Patient Reported Outcomes in Patients With Moderate-to-severe Psoriasis in Canada
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Sex: All
Age: 18 - 70+
Code: NCT04864886
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Safety and Pharmacokinetics of LPX-TI641 in Atopic Dermatitis and Psoriasis
for
Atopic Dermatitis (AD), Psoriasis (PsO)
Location: Fargo ND, Dallas TX
Sponsor: LAPIX Therapeutics Inc.
Sex: All
Age: 18+
Code: NCT06982352
Phase1, Recruiting
Active & Responsive
Creating Health Course Study for People With Rheumatological Conditions
for
Rheumatoid Arthritis, Sjogren's Syndrome,
Location: Iowa City IA
Sponsor: Terry L. Wahls
Sex: All
Age: 18 - 70+
Code: NCT07180537
Recruiting
Active & Responsive
A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab
for
Juvenile Psoriatic Arthritis
Location: Little Rock AR, Washington D.C. DC, Hollywood FL,
Sponsor: AbbVie
Sex: All
Age: 5 - 17
Code: NCT06100744
Phase3, Recruiting
New
Efficacy and Safety of a Botanical Total Coumarin (TC) Cream in Treating Patients With Psoriasis Vulgaris (PLANTCOAT-III)
for
Psoriasis Vulgaris, Topical Administration, Phase III
Location: New York NY
Sponsor: Psoriasis Research Institute of Guangzhou
Sex: All
Age: 18 - 70
Code: NCT07426120
Phase3, Recruiting
Low-Dose (17.5 mg/Day) Acitretin: Comparable Efficacy Without the Side Effects?